We have been making some updates on the site. If you have any issues with FAST Graphs, please clear your cache and cookies and that will likely resolve any issues with accessing the site.

BMY

FAST Graphs Analyze out Loud Video Bristol-Myers Squibb

2020-05-06

Research Articles

Disclosure: Long BMY. Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may not achieve the earnings growth as […]

Subscriber Request Series: Celgene Corp (NAS:CELG) and Bristol Myers (NYS:BMY)

2019-07-11

Research Articles

FAST Graphs Analyze Out Loud Celgene Corp $CELG: Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and […]

6 High Yield Pharmaceutical Companies: Do They Justify the Risk?

2011-01-12

Research Articles

Introduction Today Investors are keenly focused on income while simultaneously very risk averse.This current behavior brings with it a level of frustration.The appetite for yield is high precisely at a time when yields on the traditionally safest investments like bonds and CDs, etc. are at historic lows.On the other hand, dividend yields on many blue-chip […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.